Alzheimer's disease (AD) is a neurodegenerative disease associated with human aging.
Ten percent of individuals over 65 years have AD and its prevalence continues to rise with …

The retina is an emerging CNS target for potential noninvasive diagnosis and tracking of
Alzheimer's disease (AD). Studies have identified the pathological hallmarks of AD …

The incidence of Alzheimer's disease (AD), the leading cause of dementia, increases rapidly
with age, but why age constitutes the main risk factor is still poorly understood. Brain ageing …

Philosophers defined the eye as a window to the soul long before scientists addressed this
cliché to determine its scientific basis and clinical relevance. Anatomically and …

Alzheimer′ s disease (AD) is the most common neurodegenerative disorder to date.
Neuropathological hallmarks are β‐amyloid (Aβ) plaques and neurofibrillary tangles, but the …

The belief that the vertebrate brain functions normally without classical lymphatic drainage
vessels has been held for many decades. On the contrary, new findings show that functional …

MicroRNAs (miRNAs) are a class of small (∼ 22 nucleotides) noncoding RNAs involved in
the regulation of gene expression at the post‐translational level. It is estimated that 30–90 …

The neurosensory retina emerges as a prominent site of Alzheimer's disease (AD)
pathology. As a CNS extension of the brain, the neuro retina is easily accessible for …

This week marks a century since the first description of Alzheimer's disease (AD). Despite
approval of several drugs for AD, the disease continues to rob millions of their memories and …

There is compelling evidence that Alzheimer's disease (AD) amyloid-β (Aβ) deposition is
associated with a local inflammatory response, which is initiated by the activation of …